市场调查报告书
商品编码
1525475
全球数位病理学市场评估:按产品类型、应用、最终用户、地区、机会、预测(2017-2031)Digital Pathology Market Assessment, By Product, By Type, By Application, By End-user, By Region, Opportunities and Forecast, 2017-2031F |
全球数位病理市场规模预计将从 2023 年的 10 亿美元增至 2031 年的 25.7 亿美元,2024-2031 年预测期间复合年增长率为 12.50%。该市场是医疗IT和生物技术产业的重要组成部分,是医疗市场中成长速度最快的。数位病理技术的日益采用、人工智慧和机器学习的整合以及慢性病盛行率的增加等因素正在推动市场发展。
数位病理学涉及从数位标本载玻片收集的数据的管理。数位病理学使用基于电脑技术的虚拟显微镜。由玻璃製成的数位幻灯片可以在电脑萤幕上管理、分享、检查和分析。现代病理学需要新的方法,而数位病理学提供了许多好处,包括改进的分析、更少的错误、更好的视觉化、更流畅的工作流程和更短的周转时间。机器学习和人工智慧在医学领域的进步正在扩展数位病理学领域,并且使用全玻片成像 (WSI) 的诊断医学应用正在获得认可。这些应用的目标是实现准确且廉价的疾病诊断、预后和预测。
AGFA Healthcare NV 和 Corista LLC 宣布于 2024 年 7 月推出北美病理数位转型整合解决方案。这项先进技术帮助病理部门克服从模拟环境过渡到数位环境的课题。这些课题包括降低复杂性、加强临床协作和提高营运效率。AGFA 的企业影像平台可让您跨多个服务线部署安全且可自订的影像整合方法。
慢性病增加将加速市场需求
糖尿病和心臟病等长期健康问题的增加给医院及其住院部带来了巨大的压力。智慧型手机应用程式和医疗设备等行动医疗技术使患者能够监控自己的健康状况、照顾自己并定期在家中与医生交谈。British Heart Foundation的报告显示,全球约有2亿人患有冠状动脉疾病(CAD),其中男性占冠心病患者的57.89%,女性占42.11%。根据IDF(International Diabetes Federation)的数据,全球有超过 5.37 亿成年人患有糖尿病。
整合人工智慧和机器学习发展数位病理市场
随着越来越多的实验室使用人工神经网路来增强分析,科技的进步使得数位病理学测试越来越受欢迎。全玻片成像(WSI)是其在数位病理学中应用的一个突出例子。显微镜载玻片由 WSI 进行数位扫瞄并载入到电脑中。然后,用户可以使用影像增强和数位转换技术进行基于人工智慧的分析。开发有效的癌症治疗方法一直是医学专业人员面临的问题。儘管传统的活检结果非常准确,但处理和解释数据需要很长时间。人工智慧系统可以快速收集和分析必要的数据,做出准确的癌症诊断并提供结果。2024年5月,Microsoft宣布与华盛顿大学和Providence健康网路合作,推出数位病理诊断的全幻灯片AI模型。研究团队提出了一种机器学习模型,该模型基于现实世界中进行的全玻片组织分析中最大的人工智慧培训项目之一。
本报告针对全球数位病理市场进行研究与分析,提供市场规模与预测、区域市场前景、市场动态、竞争格局等。
Global digital pathology market is projected to witness a CAGR of 12.50% during the forecast period 2024-2031, growing from USD 1.00 billion in 2023 to USD 2.57 billion in 2031. The global digital pathology market is an important part of the healthcare IT and biotechnology industry, accounting for one of the fastest growth rates in the healthcare market. Factors are driving the market such as increasing adoption of digital pathology technologies, integration of AI and machine learning, and growing prevalence of chronic diseases.
Digital pathology deals with the management of data gathered from digital specimen slides. Virtual microscopy is used in digital pathology, using computer-based technologies. Digital slides made from glass can be managed, shared, examined, and analyzed on a computer screen. Modern pathologies need new approaches as digital pathology offers numerous benefits such as improved analysis, reduced errors, better views, smooth workflow, and reduced turnaround times. Due to the advancements in machine learning and artificial intelligence in healthcare, the field of digital pathology is expanding and recognizing applications in diagnostic medicine using whole-slide imaging (WSI). The goal of these applications is to achieve accurate and affordable disease diagnosis, prognosis, and prediction.
AGFA Healthcare N.V. and Corista LLC announced the launch of their integrated solution for digital transformation in pathology in North America in July 2024. This advanced technology helps pathology departments overcome the difficulties that occur in moving from an analog to a digital environment. These difficulties involve reducing complexity, enhancing clinical cooperation, and facilitating operational efficiency. The recognized enterprise imaging platform from AGFA makes it possible to implement a safe, customizable picture consolidation approach across several service lines.
Increasing Prevalence of Chronic Diseases to Accelerate the Market Demand
The rise in long-term health problems, such as diabetes and heart issues, puts a lot of pressure on hospitals and their inpatient units. The burden makes people want mobile health (mHealth) options that can help them handle ongoing health conditions better. mHealth technologies such as phone apps and medical devices let patients keep an eye on their health from home, take care of themselves, and talk to their doctors on a regular basis. As per a report from British Heart Foundation, around 200 million people have coronary artery disease (CAD), men and women constituting 57.89% and 42.11%, respectively of the global coronary artery disease patients globally. As per IDF (International Diabetes Federation), more than 537 million adults are living with diabetes globally.
Integration of Artificial Intelligence and Machine Learning to Evolve Digital Pathology Market
Digital pathology has become increasingly popular as a result of technology advancements, as more laboratories use artificial neural networks to enhance their analysis. Whole slide images (WSI) are a prominent example of applications in digital pathology. The microscope slide is digitally scanned by WSI and loaded into a computer. After that, users can use picture improvement and digital transformation methods for AI-based analysis. It has always been a problem for medical professionals to develop effective cancer treatments. The findings of a traditional biopsy are quite accurate, but processing and interpreting the data takes a long time. Artificial intelligence systems can quickly collect and analyze the necessary data, provide accurate cancer diagnoses, and produce results. In May 2024, Microsoft announced its collaboration with the University of Washington and Providence health network with the aim of launching whole-slide AI model for digital pathology. The researchers presented a machine learning model based on one of the most extensive AI training projects in whole-slide tissue analysis conducted in real-world settings.
Device Segment Dominates the Global Digital Pathology Market
The device segment had a dominant share of the global digital pathology market. It is expected to maintain at a lucrative pace throughout the forecast period. The scanner and slide management system are part of the device segment. The growing use of digital pathology for higher-resolution imaging in academic research projects is one of the major reasons behind the segment's growth. The VENTANA DP 600 slide scanner, a next-generation high-capacity device by F. Hoffmann-La Roche Ltd. that produces high-resolution digital pictures of stained tissue samples, assists in cancer diagnosis and treatment planning after the CE mark approval in June 2022.
North America Dominates the Global Digital Pathology Market
In 2023, North America held a dominant position in the global digital pathology market. This was attributed to several factors, including the development of technologically advanced pathologies due to government initiatives, ongoing deployment of R&D investments, presence of healthcare regulatory bodies, rising adoption of digital imaging, and the presence of key market players in the region who were focused on improving living and health conditions of individuals with chronic diseases. To participate in the Early Access Program, PathAI released AISight, a digital pathology platform, in March 2023 in top health systems of 13 nations, reference laboratories, medical facilities, and independent pathology organizations. Additionally, the market is growing due to the growing use of digital pathology in academic research and illness diagnostics. In June 2024, Roche announced that its whole-slide imaging system, the Roche Digital Pathology Dx, received FDA 510(k) approval. The technology analyzes and interprets digital images of scanned pathology slides to facilitate pathologists' diagnostic process. Roche is dedicated to make routine medical diagnosis possible with its digital pathology solutions, and the approval was the first step in that direction.
Future Market Scenario (2024-2031F)
A completely digital workflow from electronic microscopes to cloud-based storage and analysis is expected to accelerate digital pathology market in the forecast period. This will make remote collaboration possible and turn diagnosis faster and more effective.
Artificial intelligence and deep learning technologies will automate tasks, such as pattern recognition and computer-aided diagnosis, in digital pathology market.
More advanced applications, such as forecasting genetic alterations and treatment response based on anatomical characteristics of tissue samples, will be possible through the integration of digital pathology with AI and machine learning.
Digital pathology will enable pathologists to access and interpret slides remotely, which is crucial when there is a projected shortage of pathologists in the future.
Key Players Landscape and Outlook
Several biotechnology companies and IT companies are growing in the digital pathology market by planning and adopting new strategies. They are complying with new strategic initiatives for digital pathology technologies to increase their market presence. New agreements, contracts, acquisitions mergers, investments, and partnerships are major ways through which the market players are trying to achieve a higher market share.
Philips and Amazon Web Services announced their partnership in March 2024 to scale its cloud storage for digital pathology solutions. By enabling more pathology laboratories to use digital processes to boost productivity, Philips and AWS will progress digital pathology and assist pathology labs in effectively managing, storing, and analyzing increasing amounts of digital pathology data.
All segments will be provided for all regions and countries covered
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.